Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus [Phase 2]
This document reports the completion of a Phase II trial evaluating PF-00299804 in patients with metastatic or recurrent Esophageal Squamous…
-
CLINICAL_TRIALS research · 2016-07-06Clinical Trial Update: The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy [Phase 3]
A Phase 3 clinical trial update evaluating different cycles of capecitabine-oxaliplatin chemotherapy in combination with chemoradiotherapy f…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma [Phase 3]
This document provides an update on a Phase III clinical trial evaluating nimotuzumab in combination with concurrent chemoradiotherapy for l…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study [Phase 2]
An open-label, single-center Phase II study from Fudan University evaluated S-1 in combination with cisplatin for recurrent or metastatic es…
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial update comparing cisplatin plus S-1 versus cisplatin plus paclitaxel as first-line treatment for metastatic esophageal squamou…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-02-01Clinical Trial Update: Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 clinical trial evaluating Nimotuzumab with Paclitaxel and Cisplatin for metastatic esophageal squamous cell carcinoma; current statu…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas [Phase 2]
An update on a Phase 2 trial evaluating Endostar in combination with vinorelbine and cisplatin as second-line therapy for advanced esophagea…
-
CLINICAL_TRIALS research · 2016-01-12Clinical Trial Update: Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating different cycles of cisplatin plus 5-fluorouracil chemoradiotherapy …
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer [EARLY_Phase 1]
This early Phase 1 clinical trial evaluates a miniaturized microscope device for detecting esophageal squamous cell carcinoma and has comple…
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer [Phase 2]
A Phase 2 trial evaluating the combination of docetaxel and gemcitabine in metastatic esophageal squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase II trial comparing XP versus XG in advanced esophageal squamous cell carcinoma has completed.
-
CLINICAL_TRIALS research · 2015-12-11Clinical Trial Update: Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer [Phase 3]
This document reports a Phase 3 clinical trial evaluating time-optimizing endoscopic photodynamic therapy for esophageal cancer (adenocarcin…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer [Phase 2]
Phase 2 trial investigating concurrent radiotherapy with weekly PF chemotherapy (cisplatin and 5-fluorouracil) for postoperative locoregiona…
-
CLINICAL_TRIALS research · 2015-11-11Clinical Trial Update: Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy [Phase 3]
This Phase 3 trial update investigates different cycles of capecitabine used with radiotherapy in stage II–III esophageal squamous cell carc…
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus [Phase 2]
Phase 2 clinical trial update evaluating paclitaxel or S-1 in combination with cisplatin-based chemoradiotherapy for esophageal squamous cel…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy [Phase 2]
This Phase 2 trial investigated the combination of pralatrexate and docetaxel in patients with Stage IV esophageal or gastroesophageal cance…
-
CLINICAL_TRIALS research · 2015-10-07Clinical Trial Update: A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma [Phase 3]
This report covers a Phase III clinical trial comparing adjuvant chemoradiotherapy to adjuvant radiotherapy for esophageal squamous cell car…
-
CLINICAL_TRIALS research · 2015-09-01Clinical Trial Update: Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial update evaluating adjuvant paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma; curren…
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial update on nimotuzumab combined with chemoradiation for locally advanced esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS research · 2015-07-07Clinical Trial Update: CIK in Treating Patients With Esophageal Cancer [Phase 2]
A Phase 2 clinical trial evaluating cytokine-induced killer cells for esophageal squamous cell carcinoma is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]
This document reports the results update of a Phase 2 trial comparing paclitaxel with or without cixutumumab as second-line therapy for meta…
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous …
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Proton Beam Therapy to Treat Esophageal Cancer [Phase 1]
A Phase 1 clinical trial evaluating proton beam therapy for esophageal cancer was terminated. The study included patients with esophageal sq…
-
CLINICAL_TRIALS withdrawal · 2015-03-05Clinical Trial Update: Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus [Phase 2]
Phase 2 neoadjuvant trial of nimotuzumab plus nab-paclitaxel for esophageal squamous cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-05Clinical Trial Update: Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus [Phase 2]
A Phase 2 trial of nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy for esophageal squamous cell carcinoma has been withdra…